MENU
+Compare
VERV
Stock ticker: NASDAQ
AS OF
Jul 10 closing price
Price
$11.09
Change
-$0.00 (-0.00%)
Capitalization
990.47M

VERV Verve Therapeutics Forecast, Technical & Fundamental Analysis

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines... Show more

VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VERV with price predictions
Jul 10, 2025

VERV in upward trend: 10-day moving average crossed above 50-day moving average on June 05, 2025

The 10-day moving average for VERV crossed bullishly above the 50-day moving average on June 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for VERV moved above the 200-day moving average on June 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VERV advanced for three days, in of 201 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 93 cases where VERV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on July 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VERV as a result. In of 61 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VERV turned negative on July 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 33 similar instances when the indicator turned negative. In of the 33 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERV broke above its upper Bollinger Band on June 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VERV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.086) is normal, around the industry mean (17.368). P/E Ratio (0.000) is within average values for comparable stocks, (59.372). VERV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.445). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (15.974) is also within normal values, averaging (273.506).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 95.94% to -68 cents per share on August 07

Verve Therapeutics VERV Stock Earnings Reports
Q2'25
Est.
$-0.69
Q1'25
Beat
by $0.30
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
The last earnings report on May 14 showed earnings per share of -34 cents, beating the estimate of -64 cents. With 2.43K shares outstanding, the current market capitalization sits at 990.47M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITHX37.64N/A
N/A
MFS Massachusetts Investors Tr R3
SMCPX38.21N/A
N/A
ClearBridge Mid Cap 1
AMRCX5.14N/A
N/A
American Growth One C
SSMOX11.14N/A
N/A
Steward Values Enhanced SmMidCapR6
TVLRX12.42N/A
N/A
Touchstone Value R6

VERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-0.27%
ACXP - VERV
52%
Loosely correlated
-0.20%
CRSP - VERV
49%
Loosely correlated
-1.80%
BEAM - VERV
48%
Loosely correlated
+2.66%
IVEVF - VERV
46%
Loosely correlated
N/A
AXON - VERV
44%
Loosely correlated
-9.04%
More